We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00638417
First Posted: March 19, 2008
Last Update Posted: September 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
OrtoMedic A/S, Oslo
Scandinavian Customized Prosthesis (SCP)
Information provided by (Responsible Party):
Norwegian University of Science and Technology
  Purpose

The aim of the study is to improve hospital treatment and rehabilitation of patients with hip arthroplasty to help the patients to regain functional ability in the shortest possible time, and reduce hospital and rehabilitation time to save costs for the patient and society.

Optimal reconstruction of the hip joint and the effect of an intensive physical training programme are compared to conventional rehabilitation programmes.


Condition Intervention
Osteoarthritis, Hip Procedure: Maximal strength training

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Treatment and Rehabilitation of Patients With Hip Arthroplasty to Regain Walk and Work Efficiency and Quality of Life

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Enrollment: 24
Study Start Date: January 2006
Study Completion Date: November 2007
Primary Completion Date: March 2006 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Maximal strength training
    Group 1 intervention: maximal strength training Group 2 intervention: conventional rehabilitation programme
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary osteoarthritis
  • Unilateral osteoarthritis
  • Age below 65 yrs
  • ASA group 1-2

Exclusion Criteria:

  • Pregnancy
  • Age below 18 yrs
  • Cardiovascular disease
  • Diseases in the musculoskeletal system that could influence on training
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00638417


Locations
Norway
Faculty of Medicine, NTNU
Trondheim, Norway, 7489
Sponsors and Collaborators
Norwegian University of Science and Technology
OrtoMedic A/S, Oslo
Scandinavian Customized Prosthesis (SCP)
Investigators
Principal Investigator: Jan Hoff, prof Norwegian University of Science and Technology
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00638417     History of Changes
Other Study ID Numbers: 4..2005.1527a
First Submitted: March 12, 2008
First Posted: March 19, 2008
Last Update Posted: September 21, 2017
Last Verified: September 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases